Sign In
21 Oct 2016 16:37
GW Pharmaceuticals plc
Posting of Shareholder Circular
London, UK, 21 October 2016: GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW" or "the Company"), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, confirms that further to the announcement made on 19 October, a circular has been published and has been posted to shareholders in relation to the Company's intention to cancel the admission of its 0.1 pence ordinary shares to trading on AIM on 5 December, 2016.
A copy of the Circular is available on the Company's website at the following URL: http://www.gwpharm.com.
Enquiries:
GW Pharmaceuticals plc | |
Stephen Schultz, VP Investor Relations (U.S.) | 917 280 2424 / 401 500 6570 |
FTI Consulting (Media Enquiries) | |
Ben Atwell / Simon Conway | +44 20 3727 1000 |
Peel Hunt LLP (UK NOMAD) | |
James Steel | +44 20 7418 8900 |
GWP.L (GWP)
Follow the stocks
